Lexicon Pharmaceuticals (LXRX) EBITDA Margin Growth (5y) (2015 - 2026)
Lexicon Pharmaceuticals (LXRX) EBITDA Margin Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Lexicon Pharmaceuticals | 1.04 Bn | 846.13 Mn | 653,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 383,953.00 |
| Mar 31, 2026 | 7.72 Mn |
| Dec 31, 2025 | 347,867.00 |
| Jun 30, 2025 | 25.83 Mn |
| Mar 31, 2025 | -125,421.00 |
| Dec 31, 2024 | 41,776.00 |
| Sep 30, 2024 | -371,818.00 |
| Jun 30, 2024 | -120,450.00 |
| Mar 31, 2024 | -343,134.00 |
| Dec 31, 2023 | -602,899.00 |
| Sep 30, 2023 | -3.03 Mn |
| Jun 30, 2023 | -1.50 Mn |
| Jun 30, 2022 | -6.83 Mn |
| Dec 31, 2020 | -381,716.00 |
| Jun 30, 2020 | -25.12 Mn |
| Mar 31, 2020 | 69,973.00 |
| Dec 31, 2019 | -52,500.00 |
| Sep 30, 2019 | 970,531.00 |
| Jun 30, 2019 | 170,618.00 |
| Mar 31, 2019 | 1.03 Mn |